Lantern Pharma Inc. Common Stock LTRN
$0.86
-13.99%
at last close
Financials (TTM)
- Revenue
- —
- Net Income
- $-18,652,935
- Net Margin
- —
- Return on Equity
- 579.78%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- -3.99
- Price / Sales
- —
Over the trailing twelve months, Lantern Pharma Inc. Common Stock generated revenue of — and net income of $-18,652,935.
Key Stats
- Last Close
- $0.86
- Market Cap
- $12.85 million
- 52-Week Range
- $0.84 – $4.70
- Average Volume
- 246K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.